Do B vitamins protect your memory?

The short answer: taken together, the trials show a benefit from B vitamin supplementation on cognitive function that is real but small, and it shows up most clearly in people with raised homocysteine or low folate, taken over long periods. It is not a memory cure, and several careful reviews find the effect shrinks to almost nothing once the weaker studies are set aside.

What the trials actually found

A large meta-analysis pooling 95 studies and over 46,000 participants found that B vitamin supplementation was associated with a small improvement in Mini-Mental State Examination scores, and that this held even when placebo groups were declining (systematic review, 2022). The benefit was only detectable in interventions lasting more than 12 months, not in shorter trials, and it appeared in people without dementia rather than those who already had it. The same analysis found that lower dietary folate, and higher homocysteine, were linked to greater risk of dementia and cognitive decline — but B12 or B6 status alone was not.

A more recent meta-analysis restricted to people aged 60 and over, using only randomised trials of six months or longer, found a similarly modest picture (systematic review, 2025). Once statistical outliers and single-blind studies were removed, the effect on global cognitive function dropped to a very small size, though the certainty of that smaller estimate was rated high. In other words, the more rigorously the data were filtered, the smaller — but more dependable — the effect became.

A Cochrane review of vitamin and mineral supplementation across more than 83,000 participants reached a more sobering verdict for people who start out cognitively healthy: B vitamins given mainly to people in their sixties and seventies, most with a history of cardiovascular or cerebrovascular disease, had little or no effect on global cognitive function at any point up to ten years (systematic review, 2019). A Nutrients review of 23 studies on B vitamins, however, did find a small benefit on global cognition and episodic memory after supplementation lasting more than three months (systematic review, 2021).

Does it matter whether your levels are already low

This is where the picture becomes more consistent. Observational studies looking at vitamin levels rather than supplementation found that higher B12 and folate were linked to better cognition in cross-sectional comparisons, but this relationship weakened or disappeared in studies that followed people forward over time and in sensitivity analyses — leading the authors to conclude that B12, B6, and folate may not be modifiable risk factors for slowing decline in community-dwelling older adults (systematic review, 2021). A trial in people with mild cognitive impairment (the VITACOG trial) found that B vitamin treatment aimed at lowering homocysteine slowed cognitive and clinical decline specifically among those who also had good omega-3 fatty acid status at the start — when omega-3 levels were low, the B vitamins made no measurable difference (controlled trial, 2016). A related analysis from the same trial found that an enzyme called paraoxonase 1 predicted memory and processing speed in the placebo group, and that B vitamins seemed to override this association in people with mild cognitive impairment (controlled trial, 2021).

A newer network meta-analysis comparing many nutrients side by side found that folic acid combined with DHA improved memory specifically, while B vitamins alone showed more modest, biomarker-level effects — changes in homocysteine, B12, and folate levels rather than large shifts in cognitive test scores (systematic review, 2026). This lines up with a theme across the archive: nutrients rarely act alone, and how diet more broadly affects memory and thinking skills is a bigger question than any single vitamin can answer.

Who these findings apply to

Almost all of the trial data comes from people over 60, often with existing vascular disease or mild cognitive impairment, and follow-up periods clustered around one to two years or longer. The Cochrane review noted that only two included studies had participants with a mean age under 60 (systematic review, 2019). This means the archive has very little to say about what happens to B vitamin status and memory in women in their forties and fifties who are cognitively well — the question as often searched skews younger than the evidence base.

What is still unknown

Several open questions run through these studies. It is not established whether raising B vitamin intake in someone whose levels are already adequate does anything measurable — the benefit, where it appears, tends to concentrate in people with low folate or high homocysteine to begin with. It is not clear whether B vitamins alone matter, or whether their effect depends on other nutrients being in place, as the omega-3 interaction suggests. And it remains uncertain whether small improvements on cognitive test scores translate into anything a person would notice day to day, or into a lower eventual risk of dementia — the trials that measured dementia incidence directly were sparse. For a broader view of daily habits with more consistent evidence behind them, the pages on what lifestyle changes actually lower dementia risk and on exercise and cognitive function as women age cover ground this archive holds with more confidence.